JAK inhibitors: a home run for GVHD patients?

Blood. 2014 Jun 12;123(24):3691-3. doi: 10.1182/blood-2014-04-570325.
No abstract available

Publication types

  • Comment

MeSH terms

  • Animals
  • Female
  • Graft vs Host Disease / drug therapy*
  • Humans
  • Janus Kinase 2 / antagonists & inhibitors*
  • Male
  • Nitriles
  • Protein Kinase Inhibitors / therapeutic use*
  • Pyrazoles / therapeutic use*
  • Pyrimidines

Substances

  • Nitriles
  • Protein Kinase Inhibitors
  • Pyrazoles
  • Pyrimidines
  • ruxolitinib
  • Janus Kinase 2